Osaic Holdings
RLMD icon

Osaic Holdings’s Relmada Therapeutics RLMD Stock Holding History

Osaic Holdings’s Portfolio RLMD Stock Details RLMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34 Hold
5
– – ﹤0.01% 7899
2026
Q1 		$34 Hold
5
– – ﹤0.01% 7694
2025
Q4 		$24 Hold
5
– – ﹤0.01% 7730
2025
Q3 		$9 Hold
5
– – ﹤0.01% 7862
2025
Q2 		$3 Hold
5
– – ﹤0.01% 7717
2025
Q1 		$1 Sell
5
-27
-84% -$9 ﹤0.01% 7417
2024
Q4 		$16 Buy
32
+5
+19% +$12 ﹤0.01% 7334
2024
Q3 		$87 Hold
27
– – ﹤0.01% 7255
2024
Q2 		$81 Hold
27
– – ﹤0.01% 7266
2024
Q1 		$126 Hold
27
– – ﹤0.01% 7018
2023
Q4 		$112 Hold
27
– – ﹤0.01% 7103
2023
Q3 		$81 Hold
27
– – ﹤0.01% 7242
2023
Q2 		$66 Sell
27
-29
-52% -$80 ﹤0.01% 7318
2023
Q1 		$127 Sell
56
-721
-93% -$2.49K ﹤0.01% 7313
2022
Q4 		$3K Sell
777
-4,850
-86% -$42.6K ﹤0.01% 6535
2022
Q3 		$208K Buy
5,627
+850
+18% +$23.5K ﹤0.01% 3698
2022
Q2 		$91K Buy
4,777
+1,875
+65% +$40.9K ﹤0.01% 4499
2022
Q1 		$79K Buy
2,902
+2,800
+2,745% +$57.9K ﹤0.01% 4767
2021
Q4 		$3K Sell
102
-707
-87% -$15.7K ﹤0.01% 6900
2021
Q3 		$21K Buy
809
+286
+55% +$7.66K ﹤0.01% 5740
2021
Q2 		$17K Buy
523
+198
+61% +$6.88K ﹤0.01% 5759
2021
Q1 		$12K Hold
325
– – ﹤0.01% 5789
2020
Q4 		$10K Hold
325
– – ﹤0.01% 5522
2020
Q3 		$12K Buy
325
+250
+333% +$9.66K ﹤0.01% 5186
2020
Q2 		$3K Hold
75
– – ﹤0.01% 5688
2020
Q1 		$3K Buy
+75
New +$3.02K ﹤0.01% 5566

Other funds holding RLMD

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Osaic Holdings's RLMD Position: Q2 2026 in Review

Osaic Holdings held its Relmada Therapeutics (RLMD) position steady in Q2 2026 at 5 shares worth $34. The position accounts for ﹤0.01% of the portfolio, ranked #7899.

Osaic Holdings first reported a position in RLMD in Q1 2020 and has held it in 26 quarters since. The position peaked at $208K in Q3 2022. 126 funds tracked by Wall St. Rank hold RLMD as of Q2 2026.

  • Osaic Holdings held 5 shares of Relmada Therapeutics worth $34 as of Q2 2026.
  • Osaic Holdings left its Relmada Therapeutics share count unchanged in Q2 2026.
  • Relmada Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7899 holding.
  • Osaic Holdings first reported a position in Relmada Therapeutics in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Relmada Therapeutics position peaked at $208K in Q3 2022.
  • 126 funds tracked by Wall St. Rank held Relmada Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.